Albert Bourla, CEO of Pfizer explains why he chose Israel as the priority destination for his company’s SARS-COV-2 vaccine. A small population, a good healthcare system, a high degree of electronic data and an obsessive Prime Minister. And the scientific partnership has a great future.
Together we can do miracles
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.